David Antonio Sola-Del Valle, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glaucoma Drainage Implants | 2 | 2021 | 116 | 0.810 |
Why?
|
Trabeculectomy | 2 | 2021 | 162 | 0.790 |
Why?
|
Intraocular Pressure | 4 | 2021 | 1274 | 0.770 |
Why?
|
Glaucoma | 2 | 2021 | 1159 | 0.770 |
Why?
|
Lasers, Semiconductor | 1 | 2020 | 46 | 0.740 |
Why?
|
Ciliary Body | 1 | 2020 | 173 | 0.700 |
Why?
|
Phacoemulsification | 1 | 2021 | 149 | 0.670 |
Why?
|
Lipocalins | 4 | 2012 | 170 | 0.660 |
Why?
|
Acute-Phase Proteins | 4 | 2012 | 262 | 0.640 |
Why?
|
Laser Coagulation | 1 | 2020 | 326 | 0.640 |
Why?
|
Vitrectomy | 1 | 2021 | 365 | 0.620 |
Why?
|
Glaucoma, Open-Angle | 2 | 2021 | 711 | 0.570 |
Why?
|
Moraxellaceae Infections | 1 | 2015 | 8 | 0.520 |
Why?
|
Visual Acuity | 2 | 2021 | 2530 | 0.500 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2015 | 102 | 0.480 |
Why?
|
Orbital Neoplasms | 1 | 2015 | 225 | 0.430 |
Why?
|
Endophthalmitis | 1 | 2015 | 262 | 0.410 |
Why?
|
Eye Infections, Bacterial | 1 | 2015 | 235 | 0.410 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2011 | 35 | 0.390 |
Why?
|
Endoscopy | 1 | 2020 | 1784 | 0.370 |
Why?
|
Proto-Oncogene Proteins | 4 | 2012 | 4553 | 0.290 |
Why?
|
Retinal Ganglion Cells | 2 | 2017 | 771 | 0.190 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7179 | 0.140 |
Why?
|
Prosthesis Implantation | 1 | 2021 | 642 | 0.140 |
Why?
|
Nerve Fibers | 2 | 2017 | 688 | 0.130 |
Why?
|
Blister | 1 | 2015 | 86 | 0.120 |
Why?
|
Photography | 1 | 2017 | 520 | 0.120 |
Why?
|
Optic Disk | 1 | 2017 | 401 | 0.110 |
Why?
|
Postoperative Complications | 1 | 2015 | 15294 | 0.110 |
Why?
|
Cataract Extraction | 1 | 2016 | 481 | 0.100 |
Why?
|
Urinary Bladder Neck Obstruction | 1 | 2011 | 80 | 0.100 |
Why?
|
Proteinuria | 2 | 2012 | 657 | 0.100 |
Why?
|
Urethral Obstruction | 1 | 2011 | 56 | 0.100 |
Why?
|
Nephrons | 1 | 2012 | 220 | 0.090 |
Why?
|
Acute Kidney Injury | 2 | 2012 | 1971 | 0.090 |
Why?
|
Stents | 1 | 2021 | 3280 | 0.080 |
Why?
|
Kidney Function Tests | 1 | 2011 | 683 | 0.080 |
Why?
|
Treatment Outcome | 3 | 2021 | 63119 | 0.080 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2011 | 359 | 0.080 |
Why?
|
Albuminuria | 1 | 2011 | 683 | 0.070 |
Why?
|
Glomerular Filtration Rate | 2 | 2012 | 2170 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39045 | 0.070 |
Why?
|
Creatinine | 1 | 2011 | 1919 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2021 | 77426 | 0.070 |
Why?
|
ROC Curve | 1 | 2011 | 3527 | 0.060 |
Why?
|
Humans | 13 | 2021 | 744220 | 0.050 |
Why?
|
Liver Cirrhosis | 1 | 2012 | 1864 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14726 | 0.050 |
Why?
|
Adolescent | 2 | 2021 | 85759 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2011 | 2538 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2012 | 2208 | 0.040 |
Why?
|
Female | 9 | 2017 | 380197 | 0.040 |
Why?
|
Prognosis | 3 | 2012 | 29050 | 0.040 |
Why?
|
Kidney | 1 | 2012 | 7183 | 0.040 |
Why?
|
Quality of Life | 1 | 2016 | 12805 | 0.030 |
Why?
|
Tomography, Optical Coherence | 2 | 2017 | 2657 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 12075 | 0.030 |
Why?
|
Aged | 6 | 2016 | 163253 | 0.030 |
Why?
|
Cation Exchange Resins | 1 | 2012 | 21 | 0.030 |
Why?
|
Biometry | 1 | 2016 | 558 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7659 | 0.030 |
Why?
|
Chromatography, Ion Exchange | 1 | 2012 | 305 | 0.030 |
Why?
|
Middle Aged | 7 | 2017 | 213367 | 0.030 |
Why?
|
Chromatography, Gel | 1 | 2012 | 668 | 0.030 |
Why?
|
Cataract | 1 | 2016 | 834 | 0.020 |
Why?
|
Urinalysis | 1 | 2012 | 369 | 0.020 |
Why?
|
Functional Laterality | 1 | 2016 | 2290 | 0.020 |
Why?
|
Male | 7 | 2017 | 350027 | 0.020 |
Why?
|
Adult | 5 | 2016 | 214035 | 0.020 |
Why?
|
Atrophy | 1 | 2012 | 1582 | 0.020 |
Why?
|
Risk Factors | 2 | 2012 | 72280 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3509 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 25043 | 0.020 |
Why?
|
Fibrosis | 1 | 2012 | 2029 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3871 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2012 | 2204 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5180 | 0.020 |
Why?
|
Prospective Studies | 2 | 2017 | 53280 | 0.010 |
Why?
|
Biopsy | 1 | 2012 | 6757 | 0.010 |
Why?
|
Cohort Studies | 2 | 2012 | 40559 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2016 | 57768 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13409 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15070 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9582 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13280 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 13885 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15538 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2011 | 21752 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 17449 | 0.010 |
Why?
|
United States | 1 | 2016 | 69867 | 0.000 |
Why?
|